FINERENONE IN CHRONIC KIDNEY DISEASE AND TYPE 2 DIABETES: A FIDELITY ANALYSIS OF LEFT VENTRICULAR HYPERTROPHY
Therapeutic Area: Kidney Disease Background: Left ventricular hypertrophy (LVH) is a predictor of cardiovascular (CV) disease and associated morbidity and mortality. Patients with chronic kidney disease (CKD), type 2 diabetes (T2D) have a higher prevalence of LVH. In this exploratory analysis we inv...
Збережено в:
| Автори: | , , , , , , , , , |
|---|---|
| Формат: | Artigo |
| Мова: | Inglês |
| Опубліковано: |
Elsevier
2023-09-01
|
| Серія: | American Journal of Preventive Cardiology |
| Онлайн доступ: | http://www.sciencedirect.com/science/article/pii/S2666667723000855 |
| Теги: |
Немає тегів, Будьте першим, хто поставить тег для цього запису!
|